Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain) [7]

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 2, 2007, Pages 450-452

  Oliver, Maria A ^a   García Delafuente, Celia ^b   Cano, Maria E ^b   Pérez Hernéndez, Flora ^c   Martínez Martínez, Luis ^b   Albertí, Sebastián ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c Servicio Cantabro de Salud   (Spain)

Author keywords

Emm type; Group a streptococcus; Macrolide resistance

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ERYTHROMYCIN; GENOMIC DNA; MACROLIDE; METHYLTRANSFERASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; CORRELATION ANALYSIS; DRUG USE; EPIDEMIC; FINLAND; GENOTYPE; HUMAN; LETTER; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PREVALENCE; SPAIN; STREPTOCOCCUS GROUP A; TONSILLITIS;

ANTI-BACTERIAL AGENTS; CLONE CELLS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; ERYTHROMYCIN; GENOTYPE; HUMANS; MACROLIDES; PHENOTYPE; SPAIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 34547841509     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm174     Document Type: Letter

References (6)

1. Pérez-Trallero E, García-de-la-Fuente C, García-Rey C et al. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob Agents Chemother 2005; 49: 1965-72.
2. Baquero F, Blázquez J. Evolution of antibiotic resistance. Trends Ecol Evol 1997; 12: 482-7.
3. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441-6.
4. Albertí S, García-Rey C, Domínguez MA et al. Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility. J Clin Microbiol 2003; 41: 2385-90.
5. Tamayo J, Pérez-Trallero E, Gómez-Garces JL et al. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004. J Antimicrob Agents 2005; 56: 780-2.
6. Silva-Costa C, Ramirez M, Melo-Cristino J et al. Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal. Antimicrob Agents Chemother 2005; 49: 2109-11.